Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
87.50    0.00 (0.00%)
Bid:
85.00
Ask:
90.00
Spread: 5.00 (5.882%)
Market Cap: £5.75m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Non-Executive Director Appointments

26 Feb 2026 07:00

RNS Number : 4441U
Crimson Tide PLC
26 February 2026
 

26 February 2026

Crimson Tide plc

("Crimson Tide", the "Company" or the "Group")

 

Non-Executive Director appointments

 

The Board of Crimson Tide plc (AIM: TIDE), the provider of the mpro5 process management platform, is delighted to announce the appointments of Nicky Chenery and Ira Roxburgh as Non-Executive Directors of the Company.

 

Nicky has over 20 years' experience building go-to-market functions and scaling SaaS businesses. Most recently, Nicky has held senior leadership roles across a number of B2B organisations, including Wix, DeepL and SafetyCulture, following earlier experience at Adobe and Yell.

 

Ira has over 18 years' experience in product leadership, with a strong emphasis on global product development, scaling products and maximising capital efficiency across both consumer and B2B sectors. Most recently, Ira has served as Chief Product Officer at Checkatrade and before that, Zettle by PayPal, following earlier senior product roles at Funding Circle, Expedia, Amazon and Microsoft.

 

Nicky and Ira will join the Company's Remuneration Committee and Audit Committee, each of which is chaired by James Joyce, Non-Executive Director of the Company.

 

Chris Fielding, Non-Executive Chair of Crimson Tide, commented:

"We are delighted to announce the appointments of Nicky and Ira and look forward with excitement to the contributions that both will undoubtedly make to our developing business."

 

Jon Clarke, Chief Executive Officer of Crimson Tide, commented:

"We have ambitious growth plans for the business and have carefully considered where we can further strengthen the Board to support those ambitions. The two key areas identified were product and go-to-market execution. Ira brings significant experience in defining and executing product strategy, having led product teams for some of the most widely used platforms globally.

 

Nicky has a strong track record of building high-performing commercial teams and delivering sustained revenue growth. Nicky's experience at SafetyCulture, a business operating within our space, will be particularly valuable, having scaled the EMEA region from an early stage through an effective land-and-expand strategy aligned with our own. I am delighted to welcome both appointments to the Board and believe they will play an important role in supporting the Company's growth strategy."

 

Further disclosures pursuant to the AIM Rules for Companies:

 

Nicky Chenery's full married name is Nicola Suzanne Gardiner (nee Chenery). Nicky is aged 50 and has not held any directorships or partnerships in the past five years.

 

Ira Roxburgh's full married name is Irina Roxburgh (nee Ignatova). Ira is aged 53, is currently a director of Fieldlimit Limited and has not held any other directorships or partnerships in the past five years.

 

Enquiries:

 

Crimson Tide plc

Chris Fielding, Non-Executive Chair

Jon Clarke, Chief Executive Officer

Rachael Rowe, Finance Director

 

+44 1892 542444

Allenby Capital Limited - Nominated Adviser & Broker

Jeremy Porter / Ashur Joseph (Corporate Finance)

Tony Quirke / Lauren Wright (Sales & Corporate Broking)

+44 (0)20 3328 5656

info@allenbycapital.com

Subscribe to our news alert service: https://crimsontide.co.uk/auth/signup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUVSARNAUUUUR
Date   Source Headline
5th Jun 202612:26 pmRNSHolding(s) in Company
5th May 20267:00 amRNSYear End Trading Update
24th Apr 20267:00 amRNSAIM Director Disclosure Update
2nd Apr 20267:00 amRNS-RNew Contract Wins
9th Mar 202610:00 amRNSConcert Party Update
26th Feb 20267:00 amRNSNon-Executive Director Appointments
18th Feb 20267:00 amRNS-RRenewal of Contract
23rd Jan 20267:00 amRNSChange of Non-Executive Director
29th Dec 20259:21 amRNSHolding(s) in Company
24th Dec 20257:00 amRNSCustomer Contracts Update
4th Dec 20255:43 pmRNSHolding(s) in Company
27th Nov 20257:00 amRNSDirector/PDMR Shareholding - Grant of Options
19th Nov 20257:00 amRNSInterim Results
10th Nov 20253:14 pmRNSContract Renewal with Major Global Retailer
3rd Nov 20254:20 pmRNSHolding(s) in Company
31st Oct 20252:46 pmRNSResult of AGM
31st Oct 20259:28 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSAGM Statement
27th Oct 20254:45 pmRNSHolding(s) in Company
27th Oct 20254:43 pmRNSHolding(s) in Company
6th Oct 20257:00 amRNSAudited Full Year Results
29th Sep 20257:00 amRNSUpdate on Audited Results
22nd Jul 20257:00 amRNSAppointment of Chief Executive Officer
14th Jul 20252:40 pmRNSHolding(s) in Company
7th Jul 20257:00 amRNSContract Renewal with Major UK Wholesaler
4th Jul 20257:00 amRNSAppointment of Finance Director
12th Jun 202510:46 amRNSHolding(s) in Company
5th Jun 20257:00 amRNSAppointment of Chair, Nominated Adviser and Broker
30th May 20257:00 amRNSSecond Interim Results
29th May 20257:00 amRNSContract Renewal with Major British Supermarket
6th May 20257:00 amRNSChange of Accounting Reference Date
15th Apr 20253:58 pmRNSBoard Appointment
26th Mar 202511:00 amRNSBoard Changes
20th Mar 20252:29 pmRNSBoard Change
20th Mar 202512:36 pmRNSForm 8.5 (EPT/RI) - Amendment
20th Mar 202510:25 amRNSForm 8.5 (EPT/RI)
19th Mar 202511:50 amRNSResults of Court Meeting and General Meeting
18th Mar 20259:35 amRNSForm 8.5 (EPT/NON-RI)
17th Mar 20253:06 pmGNWForm 8.3 - Crimson Tide Plc
17th Mar 202512:00 pmRNSForm 8.5 (EPT/RI)
14th Mar 20253:05 pmGNWForm 8.3 - Crimson Tide Plc
14th Mar 202511:58 amRNSForm 8.5 (EPT/RI)
12th Mar 202512:05 pmRNSForm 8.5 (EPT/RI)
12th Mar 20259:23 amRNSForm 8.5 (EPT/NON-RI)
11th Mar 202510:32 amRNSForm 8.5 (EPT/RI)
11th Mar 20257:00 amRNSOffer Update
10th Mar 202512:01 pmRNSForm 8.5 (EPT/RI)
7th Mar 202512:23 pmRNSForm 8.3 - Crimson Tide plc
7th Mar 202510:20 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.